Want to see AU:TGH full AI Analyst Report?
Top Page
Terragen Holdings Ltd
(Sydney:TGH)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.02
▼(-15.00% Downside)
Action:Reiterated
Date:06/25/26
The score is primarily constrained by weak financial performance (declining revenue, ongoing losses, and negative operating/free cash flow). Technical indicators are relatively neutral and provide limited support, while valuation is hindered by a negative P/E tied to losses and no dividend yield data.
Positive Factors
Low leverage
A debt-to-equity of 0.11 indicates conservative leverage, giving Terragen durable financial flexibility. Lower interest obligations reduce refinancing risk and preserve cash for operations or strategic investments, helping the company withstand near-term losses while pursuing recovery.
Negative Factors
Declining revenue
Revenue contraction (reported -6.72%) is a structural concern: persistent top-line decline erodes scale, reduces operating leverage, and constrains ability to invest in product development or marketing. Over 2–6 months, continued declines could impede recovery and market positioning.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
A debt-to-equity of 0.11 indicates conservative leverage, giving Terragen durable financial flexibility. Lower interest obligations reduce refinancing risk and preserve cash for operations or strategic investments, helping the company withstand near-term losses while pursuing recovery.
Read all positive factors
Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$15.64M
Dividend YieldN/A
Average Volume (3M)27.47K
Price to Earnings (P/E)―
Beta (1Y)0.40
Revenue Growth-25.56%
EPS Growth38.24%
CountryAU
Employees15
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding823,199,000
10 Day Avg. Volume51,927
30 Day Avg. Volume27,470
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)1.27
Price to Sales (P/S)5.15
P/FCF Ratio-2.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Terragen Holdings Ltd Business Overview & Revenue Model
Company Description
Based in Coolum Beach, Australia, and founded in 1996, Terragen Holdings Limited specializes in the innovation, production, and commercialization of biological products for the agricultural sector. The company distributes its solutions throughout ...
How the Company Makes Money
null...
Terragen Holdings Ltd Financial Statement Overview
Summary
Income Statement
30
Negative
Balance Sheet
45
Neutral
Cash Flow
35
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.38M | 1.62M | 2.14M | 3.28M | 2.89M | 3.65M |
| Gross Profit | 583.15K | 792.23K | 2.06M | 3.21M | 2.62M | 3.19M |
| EBITDA | -3.82M | -4.68M | -3.50M | -3.46M | -5.67M | -6.13M |
| Net Income | -3.20M | -3.72M | -3.01M | -3.23M | -5.41M | -6.10M |
Balance Sheet | ||||||
| Total Assets | 5.84M | 8.12M | 6.95M | 6.35M | 9.22M | 14.72M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 4.81M | 4.54M | 4.17M | 6.67M | 11.64M |
| Total Debt | 483.87K | 735.45K | 542.23K | 239.37K | 332.26K | 357.96K |
| Total Liabilities | 1.07M | 1.55M | 1.63M | 1.27M | 1.46M | 1.70M |
| Stockholders Equity | 4.78M | 6.57M | 5.32M | 5.08M | 7.76M | 13.02M |
Cash Flow | ||||||
| Free Cash Flow | -3.59M | -3.03M | -2.35M | -2.91M | -4.97M | -4.93M |
| Operating Cash Flow | -3.55M | -3.03M | -2.32M | -2.81M | -4.80M | -4.52M |
| Investing Cash Flow | -661.04K | -682.43K | -132.93K | -35.20K | -118.20K | -408.02K |
| Financing Cash Flow | 932.53K | 3.87M | 2.82M | 351.00K | -52.70K | 194.92K |
Terragen Holdings Ltd Technical Analysis
Neutral
0.02
Price Trends
0.02
Negative
0.02
Positive
0.02
Negative
Market Momentum
<0.01
Positive
51.84
Neutral
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Neutral. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.84 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:TGH.
Terragen Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | AU$1.11B | -7.29 | -6.30% | ― | -1.53% | -281.84% | |
44 Neutral | AU$15.64M | -3.17 | -56.43% | ― | -25.56% | 38.24% | |
44 Neutral | AU$20.67M | -6.88 | -8.97% | ― | ― | 94.80% | |
44 Neutral | AU$16.67M | -1.95 | -102.56% | ― | 24.22% | 40.08% |
* Basic Materials Sector Average
AU:TGH
Terragen Holdings Ltd
0.02
>-0.01
-4.76%
AU:CP8
Canadian Phosphate
0.11
0.04
54.41%
AU:NUF
Nufarm Limited
2.95
0.33
12.60%
AU:AMN
Agrimin Limited
0.05
-0.04
-44.21%
AU:RLF
RLF AgTech Ltd
0.03
-0.03
-49.15%
AU:KM1
Kali Metals Limited
0.10
-0.07
-42.86%
Terragen Holdings Ltd Corporate Events
Terragen targets large-scale cattle probiotics rollout with new feedlot deals
Jul 30, 2026
Terragen Holdings Limited has secured conditional supply agreements that mark its first large-scale commercial deployment of Terragen Probiotic for Ruminants and Great Land Plus into major feedlot operations. The company signed a landmark agreemen...
Terragen strengthens executive ranks with new CFO to drive growth strategy
Jul 6, 2026
Terragen Holdings Limited has appointed Daniel Pearce as Chief Financial Officer and Joint-Company Secretary, effective immediately, strengthening its executive team as it pursues growth in biological agriculture. Pearce replaces outgoing CFO Roge...
Terragen Plans Issue of 1 Million Unlisted Options
May 28, 2026
Terragen Holdings Ltd has lodged a notice with the ASX outlining a proposed issue of up to 1,000,000 unlisted options as part of a placement or similar capital initiative. The options, which are scheduled for issue on 1 March 2027, represent a tar...
Terragen Lands First Major Feedlot Deal and Backing for Probiotic Cattle Trial
May 28, 2026
Terragen Holdings has signed its first large-scale commercial supply agreement with Ramps Ridge’s Ravensworth feedlot in New South Wales, covering a minimum 360,000 doses of Terragen Probiotic for Ruminants and Great Land Plus from late 2026...
Terragen strengthens board with appointment of WAM nominee director
May 8, 2026
Terragen Holdings has appointed Paul Whimp as a non-executive director, representing new shareholder WAM Investments Pty Ltd, strengthening the board with deep accounting, finance and strategic advisory expertise. Whimp’s broad experience ac...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.